Personalized Radiation Therapy for Intermediate to High-Risk Prostate Cancer
Part of Cancer, Kidney & urinary clinical trials.
This trial tests a new type of radiation therapy that is customized for each patient's prostate cancer. The radiation targets the tumor more precisely, which may help reduce side effects while treating the cancer effectively.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with adenocarcinoma of the prostate (the most common type of prostate cancer)
- Your cancer is classified as intermediate or high-risk by standard medical guidelines
- You have not received radiation to the pelvic area (lower abdomen/hip area) before
- You are expected to live at least 10 years from now
- You are able to attend all follow-up appointments for the study
- An MRI scan shows a suspicious area in your prostate that can be targeted
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a type of focused radiation therapy for men with intermediate or high-risk prostate cancer that hasn't spread. It aims to improve outcomes by targeting the main tumor seen on MRI.
This trial studies a type of focused radiation (“ablative radiotherapy”) for prostate tumors considered intermediate- or high-risk. It may help improve control of the cancer while aiming for acceptable side effects.
This trial tests a newer, more precise radiation treatment that gives a higher dose to the main tumor while keeping radiation to the rest of the prostate the same. It is for men with intermediate- or high-risk prostate cancer who haven't had prior prostate radiation or removal.
This trial tests a new radiation technique to better protect erectile function during prostate cancer treatment. It uses advanced imaging to precisely target the tumor while reducing harm to nearby structures.
This trial tests a precise radiation treatment for men with intermediate risk prostate cancer. It uses a special ultrasound to guide the radiation, aiming to treat the cancer while protecting healthy tissue. You should consider this if you have not had prior prostate cancer treatment and meet the risk category.
This trial tests a new way to plan prostate cancer treatment using artificial intelligence and advanced imaging. It’s for people with high-risk prostate cancer that hasn’t spread to lymph nodes or other parts of the body, and who have not had prior radiation to the prostate.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.